When survival is a popularity contest: the heartbreak of crowdfunding healthcare
Heather Bellamy’s March appointment at the Queen Elizabeth hospital in King’s Lynn didn’t go well. She had been diagnosed with acute myeloid leukemia five years before, in December 2014; now, her doctor explained gently, she had run out of options on the NHS. Bellamy, 48, would be starting a chemotherapy drug called azacytidine that could extend her life expectancy from two months to six. Her doctor asked if she had a bucket list.
Read more...